What's in your prostate cancer pathology report? - Dr. David Berman
Dr. Berman is Professor of Pathology and Molecular Medicine and Director of the Queen’s Cancer Research Institute at Queen’s University. His research focuses on basic, translational, and clinical aspects of bladder and prostate cancer. He has authored over 60 scientific publications which have helped establish embryonic signaling pathways as important and useful drug targets in cancer, have identified bladder cancer stem cells, and have helped to shape surgical pathology practice.
Dr. Berman is speaking here on how to interpret a prostate cancer pathology report.
This meeting is a recording from the September 15th, 2020 instalment of Prostate Cancer Foundation BC's Prostate Cancer Awareness Month Speaker Series 2020 which took place over Zoom. Please note that only the speaker portion of the meeting was recorded; the Q&A portion following was not to ensure the privacy of each participant.
This meeting is proudly presented by Prostate Cancer Support and Prostate Cancer Foundation BC. For more information, please visit www.prostatecancersupport.ca and www.prostatecancerbc.ca respectively.
Happy Prostate Cancer Awareness Month!
The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation BC or its employees. PCFBC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
-
Category
No comments found